1
1
11th INTERNATIONAL CONGRESS and 16th NATIONAL of CLINICAL PSYCHOLOGY

25-28 OCTOBER 2018, GRANADA (SPAIN)
1


1 Stefanie J. Schmidt
Member of the Executive Board of the Swiss Association for Behaviour Modification (AVM-CH)
SUIZA

1 English
Dr. Phil. Stefanie J. Schmidt is am a member of the executive board of the Swiss Association for Behaviour Modification (AVM-CH). She works at the University Hospital of Child and Adolescent Psychiatry and Psychotherapy in Bern in Switzerland as a head of the section for psychotherapy research and a deputy-head of the research department for children and adolescents. After having finished her Ph.D., which dealt with Cognitive Remediation Therapy in schizophrenia patients in group settings, her main research focus is now on the early detection and intervention of mental disorders, in particular psychotic disorders, as well as on interventions to enhance resilience in children, adolescents and young adults.. Moreover, since 2010 she works as a clinical psychologist at the Early Recognition and Intervention Centre for mental crisis (FETZ Bern) providing supervision for internal and external therapists. Furthermore, she teaches at the Medical and Clinical Psychology department of the University of Bern.

ABSTRACT INVITED SIMPOSIUM
Novel approaches to deal with comorbidity in differential diagnostics and psychotherapy for children, adolescents and adults
A range of evidence-based treatments have been developed, however, they were only rarely incorporated into clinical practice, and their efficacy was substantially reduced when they were tested under clinically representative general care conditions. Possible implementation barriers accounting for these differences may be that patients in service settings have higher rates of comorbidities and more psychosocial impairments, thus rendering deviations from treatment protocols mandatory. These differences raise concerns that treatments tested in RCTs may not be applicable to patients treated in routine clinical care, because the adherence to a predefined sequence of sessions with predetermined therapy contents in RCTs may constrain the therapistís ability to adapt each therapy session to the individual treatment needs of a patient. To address these concerns, this symposium will summarize novel approaches to deal with comorbidity in differential diagnostics and treatment of primary insomnia, depressive disorders, drug addiction, ADHD, autism-spectrum disorders and risk for psychosis.